Lisata Therapeutics, Inc. Common Stock
€2.998
EUR
Last updated on --.
24h volume33.39K
24h highest2.9988 EUR
24h lowest2.8644 EUR
24h Price movement+3.28%
LSTA recent prices
24 Hours
+3.28%+€0.095337
30 days
+5.67%+€0.16034
60 days
-31.24%-€1.357
90 days
-31.51%-€1.374
Key data
Previous close2.9034 EUR
Market cap26.44M EUR
Volume33.39K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.5601 EUR
Net income (FY)-14.17M EUR
Revenue (FY)147.34K EUR
Last report dateMay 11, 2026
About Lisata Therapeutics, Inc. Common Stock
HeadquartersBASKING RIDGE
Employees (FY)21.00
Revenue per employee (FY)7.02K EUR
Net income per employee (FY)-674.83K EUR
Listed onNasdaq
LSTA conversion tables
 |  |
|---|---|
| 0.5 LSTA | 1.499 EUR |
| 1 LSTA | 2.998 EUR |
| 5 LSTA | 14.99 EUR |
| 10 LSTA | 29.98 EUR |
| |
|---|---|
| 0.5 EUR | 0.16673 LSTA |
| 1 EUR | 0.33347 LSTA |
| 5 EUR | 1.667 LSTA |
| 10 EUR | 3.334 LSTA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
LSTA is trading at €2.998, +3.28% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LSTA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LSTA is currently trading at €2.998, +3.28% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LSTA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LSTA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LSTA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LSTA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Lisata Therapeutics, Inc. Common Stock's market cap is currently 26.44M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume33.39K
24h highest2.9988 EUR
24h lowest2.8644 EUR
24h Price movement+3.28%
Start trade with LSTA Perpetual
Sign up to trade